Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Share-based Compensation: 2010-2025

Historic Share-based Compensation for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $36780.0.

  • Cryo Cell International's Share-based Compensation fell 7479.8% to $36780.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $414172.0, marking a year-over-year decrease of 4882.32%. This contributed to the annual value of $781128.0 for FY2024, which is 439.07% down from last year.
  • As of Q3 2025, Cryo Cell International's Share-based Compensation stood at $36780.0, which was down 7479.8% from $40000.0 recorded in Q2 2025.
  • Cryo Cell International's Share-based Compensation's 5-year high stood at $313174.0 during Q1 2023, with a 5-year trough of $32000.0 in Q1 2022.
  • In the last 5 years, Cryo Cell International's Share-based Compensation had a median value of $149693.0 in 2024 and averaged $143985.8.
  • As far as peak fluctuations go, Cryo Cell International's Share-based Compensation soared by 87866.88% in 2023, and later tumbled by 7752.81% in 2025.
  • Quarter analysis of 5 years shows Cryo Cell International's Share-based Compensation stood at $68000.0 in 2021, then surged by 121.92% to $150904.0 in 2022, then grew by 16.17% to $175310.0 in 2023, then dropped by 14.61% to $149693.0 in 2024, then plummeted by 75.43% to $36780.0 in 2025.
  • Its Share-based Compensation was $36780.0 in Q3 2025, compared to $40000.0 in Q2 2025 and $297392.0 in Q1 2025.